P871: ISB 1442, A FIRST-IN-CLASS CD38 AND CD47 BISPECIFIC ANTIBODY INNATE CELL MODULATOR FOR THE TREATMENT OF CD38 POSITIVE HEMATOLOGICAL MALIGNANCIES

• C. Grandclement,
• C. Estoppey,
• E. Dheilly,
• M. Panagopoulou,
• E. Martini,
• V. Labanca,
• S. De Angelis,
• J. Frei,
• A. Drake,
• A. Rubod,
• G. Gudi,
• V. Udupa,
• J. Koch Olsen,
• R. Giovannini,
• M. A. Doucey,
• E. Feldman,
• C. Konto,
• A. Srivastava,
• M. Perro,
• S. Sammicheli

Affiliations

C. Grandclement

1 Ichnos Sciences, Epalinges, Switzerland

C. Estoppey

1 Ichnos Sciences, Epalinges, Switzerland

E. Dheilly

1 Ichnos Sciences, Epalinges, Switzerland

M. Panagopoulou

1 Ichnos Sciences, Epalinges, Switzerland

E. Martini

1 Ichnos Sciences, Epalinges, Switzerland

V. Labanca

1 Ichnos Sciences, Epalinges, Switzerland

S. De Angelis

1 Ichnos Sciences, Epalinges, Switzerland

J. Frei

1 Ichnos Sciences, Epalinges, Switzerland

A. Drake

1 Ichnos Sciences, Epalinges, Switzerland

A. Rubod

1 Ichnos Sciences, Epalinges, Switzerland

G. Gudi

2 Ichnos Sciences, New York, United States of America

V. Udupa

3 Glenmark Pharmaceuticals Limited, Mahape, India

J. Koch Olsen

4 Ichnos Sciences, La Chaux-de-Fonds, Switzerland

R. Giovannini

4 Ichnos Sciences, La Chaux-de-Fonds, Switzerland

M. A. Doucey

1 Ichnos Sciences, Epalinges, Switzerland

E. Feldman

2 Ichnos Sciences, New York, United States of America

C. Konto

2 Ichnos Sciences, New York, United States of America

A. Srivastava

1 Ichnos Sciences, Epalinges, Switzerland

M. Perro

1 Ichnos Sciences, Epalinges, Switzerland

S. Sammicheli

1 Ichnos Sciences, Epalinges, Switzerland